Strategic report Governance & remuneration Financial statements Investor information Notes to the financial statements continued 8 Operating profit 2015 2014 2013 The following items have been included in operating profit: m m m Employee costs Note 9 8,030 7,520 7,591 Advertising 1,059 671 808 Distribution costs 376 325 371 Depreciation of property, plant and equipment 892 780 732 Impairment of property, plant and equipment, net of reversals 346 18 100 Amortisation of intangible assets 738 704 682 Impairment of intangible assets, net of reversals 217 157 745 Net foreign exchange losses gains 47 18 41 Inventories: Cost of inventories included in cost of sales 7,602 6,334 7,290 Write-down of inventories 488 389 338 Reversal of prior year write-down of inventories 65 169 43 Operating lease rentals: Minimum lease payments 101 133 127 Contingent rents 8 812 Sub-lease payments 7 52 Fees payable to the companys auditor and its associates in relation to the Group see below 32.5 33.7 25.7 The reversals of prior year write-downs of inventories principally arise from the reassessment of usage or demand expectations prior to inventory expiration.
Included within operating profit are major restructuring charges of 1,891 million 2014 750 million: 2013 517 million, see Note 10, Major restructuring costs.
2015 2014 2013 Fees payable to the companys auditor and its associates: m m m Audit of parent company and consolidated financial statements 7.1 4.9 5.1 Audit of the companys subsidiaries 16.1 11.2 11.0 Audit-related assurance services, including attestation under s. 404 of Sarbanes-Oxley Act 2002 4.3 4.0 3.9 Audit and audit-related services 27.5 20.1 20.0 Taxation compliance 0.3 0.6 0.6 Taxation advice 3.2 4.5 3.3 Other assurance services 1.1 8.0 1.5 All other services 0.4 0.5 0.3 32.5 33.7 25.7 In addition to the above, fees paid in respect of the GSK pension schemes were: 2015 2014 2013 m m m Audit 0.3 0.3 0.4 Other services 154 GSK Annual Report 2015
